A detailed history of Navellier & Associates Inc transactions in Mckesson Corp stock. As of the latest transaction made, Navellier & Associates Inc holds 421 shares of MCK stock, worth $221,420. This represents 0.03% of its overall portfolio holdings.

Number of Shares
421
Previous 425 0.94%
Holding current value
$221,420
Previous $228,000 7.46%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$518.81 - $607.81 $2,075 - $2,431
-4 Reduced 0.94%
421 $245,000
Q1 2024

May 13, 2024

SELL
$473.42 - $539.26 $4,260 - $4,853
-9 Reduced 2.07%
425 $228,000
Q4 2023

Feb 08, 2024

BUY
$437.42 - $470.64 $189,840 - $204,257
434 New
434 $200,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.